Epilepsy treatment: a paradigm shift is urgently need
Arquivos de Neuro-Psiquiatria; Bartmann, Ana Paula; Sander, Josemir W..
Arq. neuropsiquiatr
; 71(3): 180-182, mar. 2013.
Artículo en Inglés | LILACS | ID: lil-668768
Documentos relacionados
A review on epilepsy, current treatments, and potential of medicinal plants as an alternative treatment.
A pragmatic algorithm to select appropriate antiseizure medications in patients with epilepsy.
Which terms should be used to describe medications used in the treatment of seizure disorders? An ILAE position paper.
The association of ABCB1 gene polymorphism with clinical response to carbamazepine monotherapy in patients with epilepsy.
Improving antiepileptic drug tolerability among patients living with epilepsy: the impact of pharmaceutical care services.
Efficacy and safety of adjunctive treatment with perampanel in epilepsy patients.
Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options.
Reduction in anti-seizure medications use in pediatric patients with pharmacoresistant epilepsy submitted to surgical treatment.
Non-invasive sensory neuromodulation in epilepsy: Updates and future perspectives.
Using nirmatrelvir/ritonavir in patients with epilepsy: An update from the Israeli chapter of the International League Against Epilepsy.